News Releases
DNA Damage Caused by Cancer Treatment Reversed by ZATT Protein
October 06, 2017 - An international team led by scientists at the National Institutes of Health is the first to discover a new way that cells fix an important and dangerous type of DNA damage known as a DNA-protein crosslink (DPC). The researchers found that a protein named ZATT can eliminate DPCs with the help of another protein, TDP2. Since DPCs form when individuals receive some types of cancer treatments, understanding how TDP2 and ZATT work together to repair the damage may improve the health outcomes of cancer patients. The findings were published in the journal Science.
- 06 Oct 2017:
- DNA Damage Caused by Cancer Treatment Reversed by ZATT Protein
- 19 Sep 2017:
- Gulf Spill Oil Dispersants Associated with Health Symptoms in Cleanup Workers
- 15 Sep 2017:
- Medical History Can Point to Earlier Parkinson’s Disease Diagnosis
- 12 Sep 2017:
- NIH Awards $15 Million to Support Development of 3-D Human Tissue Models
- 07 Sep 2017:
- NIH Awards Nearly $100 Million for Autism Centers of Excellence Program
- 28 Aug 2017:
- Common Flame Retardant Chemicals May Reduce Likelihood of Clinical Pregnancy, Live Birth Among Women Undergoing Fertility Treatments
- 17 Aug 2017:
- Female Mouse Embryos Actively Remove Male Reproductive Systems
- 14 Aug 2017:
- Heavily Used Pesticide Linked to Breathing Problems in Farmworkers’ Children
- 12 Jul 2017:
- Antibiotic Nanoparticles Fight Drug-resistant Bacteria
- 07 Jul 2017:
- NORD Publishes New Rare Disease Report on Bosma arhinia microphthalmia (BAM) Syndrome
